このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

切除可能な胃がんに対する化学放射線療法と化学療法との効果と安全性: 系統的レビューとメタ解析

  • 0Nishtar Medical University, Multan, Pakistan.

|

|

まとめ

この要約は機械生成です。

化学放射線療法 (CRT) は,化学免疫療法 (CT) と比較して,切除可能な胃がんの生存率を大幅に改善し,再発を減少させます. CRTは特定の副作用を増幅しますが この致命的な病気の生存効果は顕著です

科学分野

  • 腫瘍学
  • 胃腸内科
  • 臨床試験

背景

  • 胃がんは世界中で がんによる死亡の主な原因です
  • 手術後の補助療法は,患者の生存率を向上させる上で極めて重要です.
  • この研究では,切除可能な胃がんに対する化学放射線療法 (CRT) と化学免疫療法 (CT) を評価しています.

研究 の 目的

  • 切除可能な胃がんの成人の患者のCRTとCTの有効性を比較する.
  • 回復率と全生存率を含む生存結果を分析する.
  • 局所転移と有害事象への影響を評価する.

主な方法

  • 20794人の患者を対象とした29件の研究を体系的にメタ分析した.
  • 2024年12月までの包括的なデータベース検索
  • レビューマネージャ 5.4 を使用したランダム効果モデル分析

主要な成果

  • CRTでは,リキュアンスフリー生存率 (HR: 0. 79) と全生存率 (HR: 0. 85) の改善傾向が著しく示されました.
  • CRTは局所転移の確率を大幅に低下させました (OR: 0. 60).
  • 全体の有害事象は比較可能であった.

結論

  • 化学放射線療法 (CRT) は,切除可能な胃がんの生存率を向上させ,再発を防ぐために,化学免疫療法 (CT) よりも効果的です.
  • CRTは地域の転移を効果的に減少させるが,有害事象を軽減するために放射線療法の投与量を最適化するためのさらなる調査が必要である.

関連する概念動画

Chemotherapy-Induced Nausea and Vomiting: 5-HT<sub>3</sub> Receptor Antagonists 01:27

321

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28

259

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...

Cancer Therapies 02:49

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Comparing the Survival Analysis of Two or More Groups 01:20

280

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Targeted Cancer Therapies 02:57

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...